Conn's Syndrome
Also known as: Primary hyperaldosteronism
The goals with treatment of Conn’s syndrome are to lower blood pressure to normal or near normal levels, decrease blood aldosterone levels, and resolve any electrolyte imbalances. The type(s) of treatment depend on the cause of the excess aldosterone secretion. If it is due to a single benign adrenal tumor, then the affected gland may be surgically removed. In many cases, this will completely resolve hypertension and other associated symptoms, but in others additional treatment will still be necessary to fully control blood pressure.
If the primary hyperaldosteronism is due to a cancerous tumor (rare), then organs located next to the affected adrenal gland will need to be evaluated during surgery and more than the adrenal gland may need to be removed.
If the cause of the primary hyperaldosteronism cannot be determined (idiopathic) or appears to be due to hyperplasia in both adrenals, then surgery is usually not recommended. The patient’s condition will be treated with a drug such as spironolactone to block the action of aldosterone and with one or more blood pressure drug therapies.
Patients should consult with their doctors and, when indicated, with an endocrinologist (a specialist in the endocrine system). Treatment for primary hyperaldosteronism must often be adjusted to accommodate underlying hypertension, kidney disease, congestive heart failure, and a variety of other disorders.




